Avricore Health Inc. (AVCR.V)
| Previous Close | 0.1400 |
| Open | 0.1350 |
| Bid | 0.1250 x 0 |
| Ask | 0.1400 x 0 |
| Day's Range | 0.1300 - 0.1350 |
| 52 Week Range | 0.1050 - 0.3000 |
| Volume | |
| Avg. Volume | 24,703 |
| Market Cap | 12.954M |
| Beta (5Y Monthly) | -2.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | Apr 30, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireHealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTab™ with Rexall Pharmacy Group ULC (“Rexall”). The Companies have been working closely to develop the best patient approaches and internal workflows to ensure the most successful deployment of this powerful point-of-care testing platform. “To successfully screen and manage chronic and infectious disea
- GlobeNewswire
Avricore Health Corporate Update – Company Demonstrates Strong Growth
VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) reports on its third quarter results which demonstrate significant growth in pharmacy locations offering HealthTab driving strong revenue growth and operational cashflow positivity. With demand for clinical services growing in pharmacies thanks to the ever-expanding scope and demonstrated success they are having with it; the Company expects to finish the year well ahead of t
- News Direct
Avricore Health announces HealthTab now supporting first Rexall Pharmacy walk-in clinic
Avricore Health CEO Hector Bremner joined Steve Darling from Proactive to share news regarding the company's flagship health-data management platform, HealthTab.
